Cite
Microsatellite Instability, Prognosis and Drug Sensitivity of Stage II and III Colorectal Cancer: More Complexity to the Puzzle.
MLA
Tejpar S, et al. “Microsatellite Instability, Prognosis and Drug Sensitivity of Stage II and III Colorectal Cancer: More Complexity to the Puzzle.” JNCI: Journal of the National Cancer Institute, vol. 103, no. 11, June 2011, pp. 841–44. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=104642503&authtype=sso&custid=ns315887.
APA
Tejpar S, Saridaki Z, Delorenzi M, Bosman F, & Roth AD. (2011). Microsatellite Instability, Prognosis and Drug Sensitivity of Stage II and III Colorectal Cancer: More Complexity to the Puzzle. JNCI: Journal of the National Cancer Institute, 103(11), 841–844.
Chicago
Tejpar S, Saridaki Z, Delorenzi M, Bosman F, and Roth AD. 2011. “Microsatellite Instability, Prognosis and Drug Sensitivity of Stage II and III Colorectal Cancer: More Complexity to the Puzzle.” JNCI: Journal of the National Cancer Institute 103 (11): 841–44. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=104642503&authtype=sso&custid=ns315887.